Tuberculosis Guidelines and Recommendations: Links to Resources
This page has been automatically translated from English. MSDH has not reviewed this translation and is not responsible for any inaccuracies.
Guidelines and Recommendations
- Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and Infectious Diseases Society of America PDF
Comprehensive discussion of practical approaches to controlling TB in the United States. MMWR 2005; 54 (No. RR12)
- Diagnosis and Classification of Tuberculosis in Adults and Children PDF
Clinical Infectious Disease 2017
- Guidelines on the Diagnosis and Treatment of Pulmonary Nontuberculous Mycobacterial Infection.
International Journal of Clinical Practice 2008, Dec. 62 (12) 1947-55
- Guidelines for Environmental Infection Control in Health-Care Facilities, 2003 PDF
From CDC, MMWR, June 6, 2003, 52 (RR10); 1-42
- Guidelines for Preventing the Transmission of Mycobacterium Tuberculosis in Health-Care Facilities, 2005
From CDC, MMWR, December 30, 2005, 54(RR17);1-141
- Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis PDF
Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005 No. RR-15, 1-37
- Hepatotoxicity of Antituberculosis Therapy (2006)
An official statement from the American Thoracic Society. American Journal of Respiratory and Critical Care Medicine, Volume 174, Issue 8
- Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection (cdc.gov)
- Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC PDF
MMWR, July 7, 2006, 55(RR-9); 1-44
- Targeted TB Testing and Treatment of Latent Tuberculosis Infection PDF
National guidelines for health care providers. MMWR 2000: 49 (No. RR-6)
- Treatment of Drug Susceptible Tuberculosis PDF
Clinical Infectious Disease 2016
- Treatment of Drug-Resistant Tuberculosis PDF
Guidelines for treatment of drug-resistant TB disease. American Journal of Respiratory and Critical Care Medicine, 2019
- Guidelines for the Treatment of Latent Tuberculosis Infection PDF
Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm. Rep. 2020: 69 (No. RR-1) 1-11
- Tuberculosis and Air Travel Guidelines for Prevention and Control, Second Edition PDF
Recommendations from the World Health Organization regarding the risk of TB on international flights. May 2005
- Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium Tuberculosis Infection - United States, 2010 PDF
CDC guidelines. MMWR, June 25, 2010, 59(RR-5); 1-25
- Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis PDF
Note: Guidelines start on page 7. MMWR January 16, 2009, 58(01); 7-10
- Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel
Recommendations of the National Tuberculosis Controllers Association and CDC, May 1, 2019
TB Worldwide
Related links
Last reviewed on Jul 15, 2024
request edits